IL272428A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IL272428A
IL272428A IL272428A IL27242820A IL272428A IL 272428 A IL272428 A IL 272428A IL 272428 A IL272428 A IL 272428A IL 27242820 A IL27242820 A IL 27242820A IL 272428 A IL272428 A IL 272428A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL272428A
Other languages
Hebrew (he)
Original Assignee
Kalvista Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1713660.7A external-priority patent/GB201713660D0/en
Application filed by Kalvista Pharmaceuticals Ltd filed Critical Kalvista Pharmaceuticals Ltd
Publication of IL272428A publication Critical patent/IL272428A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
IL272428A 2017-08-11 2020-02-03 Pharmaceutical compositions IL272428A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762544346P 2017-08-11 2017-08-11
GBGB1713660.7A GB201713660D0 (en) 2017-08-25 2017-08-25 Pharmaceutical compositions
PCT/GB2018/052292 WO2019030540A1 (en) 2017-08-11 2018-08-13 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL272428A true IL272428A (en) 2020-03-31

Family

ID=70976595

Family Applications (1)

Application Number Title Priority Date Filing Date
IL272428A IL272428A (en) 2017-08-11 2020-02-03 Pharmaceutical compositions

Country Status (8)

Country Link
CL (1) CL2020000356A1 (en)
CO (1) CO2020002287A2 (en)
EC (1) ECSP20017939A (en)
IL (1) IL272428A (en)
MX (1) MX2020001356A (en)
PH (1) PH12020500246A1 (en)
RU (1) RU2020109955A (en)
UA (1) UA125537C2 (en)

Also Published As

Publication number Publication date
CO2020002287A2 (en) 2020-06-09
MX2020001356A (en) 2020-03-20
RU2020109955A3 (en) 2022-01-24
RU2020109955A (en) 2021-09-14
PH12020500246A1 (en) 2021-03-15
ECSP20017939A (en) 2020-04-22
UA125537C2 (en) 2022-04-13
CL2020000356A1 (en) 2020-06-19

Similar Documents

Publication Publication Date Title
IL271657A (en) Pharmaceutical compositions
IL269061A (en) Pharmaceutical composition comprising selexipag
IL271986B1 (en) Pharmaceutical composition
IL271759B1 (en) Pharmaceutical compositions comprising entrectinib
GB201608323D0 (en) Pharmaceutical compositions
GB201705303D0 (en) Pharmaceutical compositions
GB201712159D0 (en) Pharmaceutical composition
SG11202001179YA (en) Pharmaceutical compositions
GB201804548D0 (en) Pharmaceutical compositions
GB201719447D0 (en) Pharmaceutical composition
IL272419A (en) Pharmaceutical composition
GB201705305D0 (en) Pharmaceutical compositions
HK1245073A1 (en) Pharmaceutical compositions
GB201705306D0 (en) Pharmaceutical compositions
GB201705304D0 (en) Pharmaceutical compositions
IL263999A (en) Pharmaceutical compositions
EP3727485C0 (en) Pharmaceutical composition
GB201808571D0 (en) Pharmaceutical compositions
GB201615910D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
IL272044A (en) Pharmaceutical compositions
IL271513A (en) Novel pharmaceutical composition
GB201808567D0 (en) Pharmaceutical compositions
ZA201705782B (en) Pharmaceutical compositions
IL272428A (en) Pharmaceutical compositions